Follow
Himisha Beltran
Himisha Beltran
Dana Farber Cancer Institute
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Integrative clinical genomics of advanced prostate cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
33262015
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto, K Wang, SR Downing, J He, ...
Nature biotechnology 31 (11), 1023-1031, 2013
20122013
Inherited DNA-repair gene mutations in men with metastatic prostate cancer
CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ...
New England Journal of Medicine 375 (5), 443-453, 2016
14332016
Organoid cultures derived from patients with advanced prostate cancer
D Gao, I Vela, A Sboner, PJ Iaquinta, WR Karthaus, A Gopalan, ...
Cell 159 (1), 176-187, 2014
13512014
Punctuated evolution of prostate cancer genomes
SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ...
Cell 153 (3), 666-677, 2013
13252013
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ...
Nature medicine 22 (3), 298-305, 2016
12782016
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ...
Cancer discovery 1 (6), 487-495, 2011
8542011
Genomic correlates of clinical outcome in advanced prostate cancer
W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ...
Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019
8422019
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
P Mu, Z Zhang, M Benelli, WR Karthaus, E Hoover, CC Chen, ...
Science 355 (6320), 84-88, 2017
8042017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
P Mu, Z Zhang, M Benelli, WR Karthaus, E Hoover, CC Chen, ...
Science 355 (6320), 84-88, 2017
8042017
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ...
Cancer discovery 7 (5), 462-477, 2017
7812017
The long tail of oncogenic drivers in prostate cancer
J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra, E Reznik, ...
Nature genetics 50 (5), 645-651, 2018
6622018
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
D Chakravarty, A Sboner, SS Nair, E Giannopoulou, R Li, S Hennig, ...
Nature communications 5 (1), 5383, 2014
5722014
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity
H Beltran, R Yelensky, GM Frampton, K Park, SR Downing, ...
European urology 63 (5), 920-926, 2013
5182013
Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study
R Aggarwal, J Huang, JJ Alumkal, L Zhang, FY Feng, GV Thomas, ...
Journal of Clinical Oncology 36 (24), 2492, 2018
5012018
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
4972018
Proposed morphologic classification of prostate cancer with neuroendocrine differentiation
JI Epstein, MB Amin, H Beltran, TL Lotan, JM Mosquera, VE Reuter, ...
The American journal of surgical pathology 38 (6), 756, 2014
4972014
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
BD Hopkins, C Pauli, X Du, DG Wang, X Li, D Wu, SC Amadiume, ...
Nature 560 (7719), 499-503, 2018
4742018
N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer
E Dardenne, H Beltran, M Benelli, K Gayvert, A Berger, L Puca, J Cyrta, ...
Cancer cell 30 (4), 563-577, 2016
4482016
Aggressive variants of castration-resistant prostate cancer
H Beltran, S Tomlins, A Aparicio, V Arora, D Rickman, G Ayala, J Huang, ...
Clinical Cancer Research 20 (11), 2846-2850, 2014
3872014
The system can't perform the operation now. Try again later.
Articles 1–20